418
Participants
Start Date
August 1, 2024
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
Clozapine
Participants are randomized to clozapine or second-line antipsychotics. When randomised to clozapine, they will receive clozapine for six weeks.
Second-line Antipsychotics (treatment as usual)
Participants are randomized to clozapine or second-line antipsychotics. When randomized to second-line antipsychotics, this means participants will receive treatment as usual. The physician has the choice to administer any second-line antipsychotic. More specification is not possible, as this is a choice the physician makes with the participant based on the characteristic and preference of the participant (in line with standard clinical practice).
RECRUITING
LWL-Klinik Dortmund, Bereich Forschung & Wissenschaft, Dortmund
RECRUITING
Università degli studi della Campania Luigi Vanvitelli, Naples
NOT_YET_RECRUITING
Bezirkskliniken Schwaben, Bezirkskrankenhaus Augsburg, Augsburg
RECRUITING
Medical University Innsbruck, Innsbruck
RECRUITING
Universitätsklinik für Psychiatrie und Psychotherapie Bielefeld, Bielefeld
RECRUITING
University Hospital Frankfurt am Main - Goethe University, Frankfurt am Main
RECRUITING
Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Mainz
RECRUITING
Westfälische Wilhelms-Universität Münster, Münster
RECRUITING
Universita degli Studi di Brescia, Brescia
RECRUITING
University of Cagliari, Cagliari
RECRUITING
"Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino", Turin
RECRUITING
Fundació Clínic per a la Recerca Biomèdica, Barcelona
RECRUITING
King's College London, Psychiatry & Cognitive Neuroscience, London
Universität Münster
OTHER
Dr. Inge Winter
OTHER